Cargando…
5-year efficacy of all surface laser ablation with cross-linking (ASLA-XTRA) for the treatment of myopia
BACKGROUND: The purpose of our study is to examine the long (5-year) efficacy of the all surface laser ablation (ASLA) combined with accelerated cross-linking (CXL) for the treatment of myopia without the use of mitomycin-C (MMC). METHODS: This retrospective study consisted of 202 eyes of 118 myopic...
Autores principales: | Aslanides, Ioannis M., Hafezi, Farhad, Chen, Shihao, Mukherjee, Hatch, Selimis, Vasileios, Maragkos, Ilias, Lu, Nanji, Kymionis, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286704/ https://www.ncbi.nlm.nih.gov/pubmed/32537477 http://dx.doi.org/10.1186/s40662-020-00198-z |
Ejemplares similares
-
A pharmacological modification of pain and epithelial healing in contemporary transepithelial all-surface laser ablation (ASLA)
por: Aslanides, Ioannis M, et al.
Publicado: (2015) -
Single-step transepithelial ASLA (SCHWIND) with mitomycin-C for the correction of high myopia: long term follow-up
por: Aslanides, Ioannis M, et al.
Publicado: (2014) -
Clinical Outcomes of Aberration-Free All Surface Laser Ablation (ASLA) vs. Aberration-Free ASLA Assisted by Smart Pulse Technology in High Myopia: A One-Year Follow-Up Study
por: Du, XiaoHao, et al.
Publicado: (2021) -
Comparison of single-step reverse transepithelial all-surface laser ablation (ASLA) to alcohol-assisted photorefractive keratectomy
por: Aslanides, Ioannis M, et al.
Publicado: (2012) -
Xtra-dimensional world(s)
por: Delgado, A
Publicado: (2006)